Okla. Vs. J&J Opioid-Crisis Trial Wrapped
Okla. Vs. J&J Opioid-Crisis Trial Wrapped

Introduction
Trial testimony in the high-profile case involving Johnson & Johnson (J&J) and Oklahoma state over the ravages of the opioid crisis ended on Monday.
Following eight weeks of testimony, attorneys representing the state and the pharmaceutical giant have made their final arguments in a historic bench trial. During the trial, J&J argued for an early win claiming that the state failed to produce enough evidence to support its case, whereas the state compared the defendants to 'kingpin' for fuelling the U.S. opioid epidemic. J&J had filed a motion to dismiss the lawsuit in the early weeks of the month, which was later dismissed by Oklahoma District Judge Thad Balkman. The state urged Judge Thad Balkman, to find J&J liable for the epidemic and force it to pay up to $17 billion over 30 years.
Judge Balkman affirmed that he would rule after receiving briefs from both sides due July 31.
U.S. District Judge Dan Polster is presiding over all opioid lawsuits consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation).
Latest News
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…
Tepezza Hearing Loss Trials Delayed Until Aug 2026
A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…